← Back to headlines
Pfizer Targets Post-2028 Growth with New Obesity and Cancer Drugs
Pharmaceutical giant Pfizer is banking on its new obesity and cancer drugs to drive a return to growth for the company after 2028.
5 May, 17:30 — 5 May, 17:30
Sources
Showing 1 of 1 sources
